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ABSTRACT
Although many tools have been developed to ana-
lyze small RNA sequencing (sRNA-Seq) data, it re-
mains challenging to accurately analyze the small
RNA population, mainly due to multiple sequence
ID assignment caused by short read length. Addi-
tional issues in small RNA analysis include low con-
sistency of microRNA (miRNA) measurement results
across different platforms, miRNA mapping associ-
ated with miRNA sequence variation (isomiR) and
RNA editing, and the origin of those unmapped reads
after screening against all endogenous reference se-
quence databases. To address these issues, we built
a comprehensive and customizable sRNA-Seq data
analysis pipeline––sRNAnalyzer, which enables: (i)
comprehensive miRNA profiling strategies to bet-
ter handle isomiRs and summarization based on
each nucleotide position to detect potential SNPs
in miRNAs, (ii) different sequence mapping result
assignment approaches to simulate results from
microarray/qRT-PCR platforms and a local proba-
bilistic model to assign mapping results to the most-
likely IDs, (iii) comprehensive ribosomal RNA filter-
ing for accurate mapping of exogenous RNAs and
summarization based on taxonomy annotation. We
evaluated our pipeline on both artificial samples (in-
cluding synthetic miRNA and Escherichia coli cul-
tures) and biological samples (human tissue and
plasma). sRNAnalyzer is implemented in Perl and
available at: http://srnanalyzer.systemsbiology.net/.
INTRODUCTION
The function and application of small non-coding RNAs
(ncRNA), especially microRNA (miRNA) has gained sig-
nificant interest in recent years (1). miRNAs are 17–23 nt-
long evolutionarily conserved regulatory RNAs. Numerous
reports have shown the existence of RNA molecules, in-
cluding miRNA, in various bodily fluids (2,3). These ex-
tracellular RNAs are either encapsulated in lipid vesicles
or complexed with proteins to prevent RNase degradation.
The spectrum of extracellular miRNA in various body flu-
ids correlates with physiopathological conditions, and it has
been suggested that the concentration changes of specific
extracellularmiRNAs can be used as biomarkers for disease
diagnosis (3–5). Therefore, the ability to accurately profile
and quantify the small RNA content in biological samples
is critical for further development of miRNA-based appli-
cations. Although many experimental and computational
tools have been developed (6–9), it is still a challenge to ac-
curately and comprehensively analyze the small RNA pop-
ulation (10). For miRNA, the short sequence length, high
sequence similarity among family members and sequence
length variation (isomiR) all contribute to the difficulty of
miRNAquantification. In addition, recent studies have sug-
gested that a fraction of the RNA in circulation is derived
from exogenous species including bacteria, fungi and plants
(10–14), further complicating unambiguous assignment of
the origin of many RNA species.
Due to the wealth of information provided and decreased
cost, the next generation sequencing (NGS) platform has
gradually become one of the most common tools for study-
ing small RNAs (15). TheNGS platform can resolve closely
related sequences, is not affected by sequence length vari-
ation, does not require prior knowledge of the sequence,
may provide information to identify newmiRNA sequences
and allows the profiling of exogenous RNAs in the sample.
However, most of the tools (summarized in Supplementary
Table S1) for small RNAsequencing (sRNA-Seq) data anal-
ysis deliver poor sequence mapping specificity.
To address some of the small RNA analysis problems,
particularly for miRNA, we have built a comprehensive and
customizable pipeline––sRNAnalyzer, based on the frame-
work published earlier (4,10–11). An installation package
for the pipeline and all the reference database indexes used
in the pipeline can be downloaded from http://srnanalyzer.
systemsbiology.net/. We also built a web interface for the
pipeline, which can be accessed at the same website, mainly
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for human small RNA profiling. In this paper, we introduce
the overall workflow with a description of key features, fol-
lowed by performance evaluation using a synthetic miRNA
panel and biological samples.
MATERIALS AND METHODS
Similar to all other tools for NGS-based small RNA profil-
ing, the tool described here can be grouped into three func-
tional modules (shown in Figure 1), i.e. data pre-processing,
sequence mapping/alignment and result summarization.
The sequence mapping/alignment module is designed for
two major categories, one aimed at endogenous RNA pro-
filing and the other for identifying RNA sequences derived
from exogenous species.With this modular design, sRNAn-
alyzer allows for rapid modifications of each module, for
example, adding/removing a reference sequence database,
or changing the mapping order of databases used in the
pipeline.
Data pre-processing module
In the data pre-processing module, the pipeline trims
the adapter sequences and removes empty reads (adapter
dimer). Adapter trimming is especially important for
sRNA-Seq data analysis, since most of the sequence reads
are short and may contain part or all of the adapter se-
quences. If the adapter sequences are not completely re-
moved, mapping accuracy will be significantly affected.
The module also assesses the overall sequence quality and
removes low quality and low complexity reads, such as
reads containing simple repeats––homopolymer, di- or tri-
nucleotide repeats.
Processes to trim adapters and remove low quality sequences.
To remove adapter sequences, the pipeline adapted Cu-
tadapt (16), to remove both 3′-end and 5′-end adapter se-
quences. After adapter trimming, sRNAnalyzer removes
empty reads by utilizing index sequences (i.e. a 6-mer bar-
code embedded in the primer sequence) used for individ-
ual samples during the library construction process. If no
index/barcode information is provided, the pipeline can re-
trieve index information directly from raw sequence files
by calculating the top frequency of potential index se-
quences (Supplementary File 1––Method details). sRNAn-
alyzer handles degenerate bases used in adapters, such as
those in kits from Bioo (Bioo Scientific, Austin, TX, USA),
through configuring different settings/parameters in Cu-
tadapt. The pipeline also provides options to identify and
remove other contaminant sequences commonly encoun-
tered in small RNA libraries. To reduce adapter dimer, the
Illumina TruSeq small RNA library construction kit uses
stop oligo in the library preparation process. The stop oligo
sequences (GAATTCCACCACGTTCCCGTGG) will be
incorporated into the library especially when the input
RNA concentration is low, such as libraries from various
body fluid samples. The level of stop oligo in the library
can be used as one of the criteria for library quality assess-
ment. Our pipeline removes stop oligo sequences based on
template sequences observed from experiments from syn-
thetic miRNA samples. For quality controls, the pipeline
uses Prinseq (17), to remove low-quality reads.
Generating unique sequence file. To accelerate se-
quence alignment, the pipeline uses fastx collapser
(http://hannonlab.cshl.edu/fastx toolkit/) to generate a
file where identical reads are collapsed together. The new
header of each unique FASTA sequence in the new file
contains a unique sequence ID, followed by the number
of reads that have the same sequence. When calculating
sequence abundance, the read count for each unique
sequence is added together.
Sequence mapping and alignment module
The main function of the read sequence alignment mod-
ule is to determine the sequence identity by mapping the
reads against various sequence databases. Like many other
sRNA-Seq data analysis tools, sRNAnalyzer uses Bowtie
(18) alignment results to determine the identity of sequence
reads.
Sequential mapping strategy. The pipeline follows the
‘map and remove’ strategy adapted in the original report
(11) to sequentially map reads against various databases
as described (Supplementary Figure S1). The order of
databases depends on the research focus and can be changed
by the user. The sequencemapping is based on a progressive
alignment strategy––maximum mismatch allowance pro-
gressively increases from 0 to 2 for mapping against se-
quence databases. The error tolerance can also be adjusted
by the user.
The sequence reads can map to either the positive or neg-
ative strand of the reference sequences. In the default set-
ting, the pipeline only counts reads mapped to the posi-
tive (forward) strand for various RNA sequence databases
(e.g. miRNA, piRNA, snoRNA, lncRNA, RefSeq, ncRNA
etc.), but counts readsmapped to both strands (±) forDNA
sequence databases (e.g. human genome, human micro-
biome DNA databases and bacterial genomes). For reads
mapped to the reverse (−) strand of sequences in RNA-
specific databases, the results will not be included as expres-
sion values, but their mapped locations will still be reported
since these reads may have regulatory functions.
miRNA mapping. As illustrated in Supplementary Fig-
ure S2, our pipeline directly maps read sequences against
miRNA precursor sequences (annotated with mature
miRNA locations) by applying full alignment in Bowtie,
rather than using Bowtie seed alignment option as in
sRNAbench (19). Using seed alignment (only considering
matches on a seed region, default setting is 20 nt in sRN-
Abench) cannot control mismatch tolerance outside the
seed region, and will mix RNA editing events and SNPs
with sequencing errors. The latest sRNAbench paper (19)
also mentioned the deficiency of using seed alignment. In
our pipeline, we generated composite sequence header con-
taining precursor sequence ID, and mature miRNA names
and coordinates during the construction of miRNA refer-
ence database. A mapped read will then be assigned to ei-
ther one of the corresponding mature miRNAs (either at 5′
end (-5p) or 3′ end (-3p) of the precursor sequence).
With this approach, somemiRNAIDs generated through
sRNAnalyzer do not exist in miRBase (20). For exam-
ple, hsa-miR-101–1-3p and hsa-miR-101–2-3p share the
12142 Nucleic Acids Research, 2017, Vol. 45, No. 21
Figure 1. Main framework of sRNAnalyzer. The pipeline can be divided into three functional modules which are separated by dotted lines. The data format
for each process is indicated in square brackets.
same mature sequence (hsa-miR-101–3p in miRBase 21)
but contain different sequences beyond the mature se-
quence. This strategy offers the advantage of obtaining all
length variations––isomiR associated with miRNA. With
mismatch allowance, we can also detect potentialRNAedit-
ing events and single nucleotide polymorphisms (SNPs) as-
sociated withmiRNA.We demonstrated this in a case study
using colorectal cancer (CRC) sequence dataset. To verify
potential SNPs or RNA editing issues, the pipeline will fur-
ther search each mismatch event, including both mismatch
types and coordinates on genome, against dbSNP (21).
To address the concern about validity of miRNA reper-
toires recently raised (22–24), the pipeline also provides
MirGeneDB (24) as an option for human miRNA pro-
filing with better annotations. The pipeline has modu-
lar designs on reference database mapping, which al-
lows for adding/removing a customized reference sequence
database, or changing the mapping order of databases
very conveniently (through a markup configuration file).
To summarize miRNAmapping results, sRNAnalyzer uses
two read summarization strategies: single assignment and
multiple assignment approaches first introduced in sRN-
Abench (19). Under the single assignment approach, each
read is counted only once even when it maps to multiple ref-
erence sequences. In the multiple assignment approach, all
mapped reference sequences are counted.
Single assignment for miRNA mapping. One of the diffi-
culties associated with miRNA profiling or measurement
is the extreme sequence similarity of some sequences, es-
pecially for mature miRNAs among family members (se-
quences can sometimes be identical). Under traditional ap-
proaches, identical reads from different samples may be as-
signed to different IDs, since the Bowtie aligner randomly
assigns all the best matching reference sequences as the top
hit. To solve this mapping issue, we adapted a local prob-
abilistic model (LPM) to assign each mapped read to the
most-likely miRNA within a sample (Supplementary Fig-
ure S3). This LPM is based on feature (sequence ID) rank-
ing order, which is assessed by the frequency of mapped
reads (a higher ranking order indicates the specific sequence
ID has more mapped reads). Therefore, a miRNAmapping
assignment is determined by both the alignment of individ-
ual reads and the overall mapped read count distribution
among all the miRNAs within a sample.
Weightedmultiple assignment approach for miRNAmapping.
Due to the nature of nucleic acid hybridization, which forms
the basis of both qRT-PCR and microarray platforms, the
results from qRT-PCR andmicroarray are less specific than
NGS-based profiling results. To generate results that are
in better agreement with other miRNA measurement plat-
forms, the user can also select a weighted multiple assign-
ment approach. For miRNA mapping, our default param-
eters count a perfect match (no mismatch) as 1, one mis-
match as 0.8 and two mismatches count as 0.6. Users can
also change these weight factors.
Exogenous RNA mapping––ribosomal and transfer RNA fil-
tering. Based on prior studies (4,10), most of the exoge-
nous RNAs map to various ribosomal RNAs (rRNAs)
and transfer RNAs (tRNAs) (11,25–26). Both rRNAs and
tRNAs possess high sequence similarity among different
species, which creates uncertainty about the origin of exoge-
nous RNA and a significant mapping problem due tomulti-
ple matches. In some cases, a single sequence read can map
to several thousand sequences in the database. For a more
accurate mapping result for exogenous RNAs, the pipeline
offers an option to filter out microbial tRNA and rRNA
sequences prior to exogenous sequence database mapping.
We tested the use of tRNA and rRNA for exogenous
species mapping using bacteria RNA dataset and found re-
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moving rRNA and tRNA sequences increased the accu-
racy for species assignment. However, this needs to be fur-
ther tested with additional datasets. Our pipeline does al-
low the user to bypass the rRNA and tRNA filtering step
so that user can test the mapping accuracy with or with-
out rRNA/tRNA filtering. Even though we ‘filter’ out the
tRNA and rRNA reads, the current pipeline still provides
tRNA and rRNA fragment mapping results. The reason we
call this a filtering step is to highlight the importance of
‘rRNA and tRNA filtering’ in the accuracy and specificity
of exogenous RNA mapping as shown in Results section.
Recently, there are many studies discovered possible reg-
ulatory roles and potential applications of tRNA or rRNA
fragments (27,28), especially in plasma or serum samples
(29). To make this clear, we also modified our pipeline by
adding specific human tRNA fromGtRNAdb (30) and hu-
man rRNA databases from RDP II (31) and SILVA (32)
in the mapping steps. In addition, we provide profiles for
yRNA fragments from human transcriptome mapping re-
sults by NCBI/RefSeq (33).
Result summarization module
The result summarization module provides reports for var-
ious mapping results. The results can be summarized at dif-
ferent levels––from individual transcripts (such as individ-
ual miRNAs) to different phyla.
miRNAmapping results. The pipeline can summarize read
counts for each individual mature or precursor miRNA, as
well as aggregate read counts for each nucleotide across in-
dividual precursor miRNAs. Moreover, sRNAnalyzer pro-
vides mismatch counts and rates for all the possible 16 mis-
match types (A|T|G|C > A|T|G|C|N) at each position. This
function allows researchers to review miRNA sequence
variations in the sample.
Summarization based on taxonomy. Besides detailed small
RNA expression profiles, the mapping results can also be
viewed at different taxonomy levels (including Phylum,
Class, Order, Family, Genus, Species and Strain/Scientific
Name). The taxonomy annotation is based on two sources:
(i) descriptions in the sequence header from the original ref-
erence sequence databases, and (ii) taxonomy information
from gi taxid obtained fromNCBI (mainly for bacteria and
nt database from NCBI). For convenience, common names
for different species are also added to the summarization
results.
Datasets used in the performance evaluation study
To assess the performance and determine various parame-
ters used in sRNAnalyzer, we used datasets generated using
both artificial and biological samples, including synthetic
miRNA, bacterial culture, human tissue and plasma sam-
ples.
Synthetic miRNA. A total of 286 synthetic miRNAs that
are commonly observed in circulation were synthesized by
Integrated DNA Technologies (Coralville, IA). We ran-
domly assigned synthetic miRNAs to each of three plates
(Plate 1, Plate 2 and Plate 3) respectively. Six combina-
tions of different concentrations from these three synthetic
miRNAs plates were subjected to small RNA sequencing
(GEO accession number: GSE94912), qRT-PCR (Exiqon,
Woburn, MA, USA) and microarray (Exiqon, Woburn,
MA, USA) analyses (Supplementary File 3––Tables for
synthetic miRNA pool information and measurements).
The synthetic miRNA samples are labeled with ‘Plat-
form or library kit name’ ‘Plate 1 concentration’ ‘Plate
2 concentration’ ‘Plate 3 concentration’. For example,
NEB 10 1 0.1 represents the synthetic miRNA sample with
NEB NEBNext® Small RNA Library Prep library kit
(New England Biolabs, Ipswich, MA, USA) using 10 ng of
pooled syntheticmiRNAs from plate 1, 1 ng of pooledmiR-
NAs from plate 2 and 0.1 ng of pooled miRNAs from plate
3.
Bacterial culture. To test the capability and accuracy of
sRNAnalyzer on exogenousRNAmapping, we re-analyzed
the small RNAseq data from our prior report (25) on
RNA in outer membrane vesicles (OMV) derived from Es-
cherichia coli K-12 substrain MG1655. The bacteria were
grown in Luria-Bertani (LB) broth at 37◦C. The small RNA
libraries from the bacterial culture, OMV-containing super-
natant, OMV-free supernatant and unused fresh LB me-
dia were generated with the Illumina TruSeq Small RNA-
Seq Prep Kit (San Diego, CA, USA). In the original study,
processed reads (after removing adapter sequences) were
mapped directly against the E. coliK-12 substrainMG1655
reference genome (accession number: NC 000913.2).
Human tissue and plasma data. To test the performance of
sRNAnalyzer on human samples, we used two public do-
main datasets. A human CRC tissue miRNA study (GEO
accession number: GSE46622 or SRA accession number:
SRP022054) (34) and our prior human CRC plasma study
(SRA accession number: ERP002414) (11). These datasets
allow us to compare the results from sRNAnalyzer with
published results. The CRC tissue study contains the pri-
mary tumor tissues, adjacent normal colon epithelium and
liver metastases from eight patients. The small RNA li-
braries were made with the Illumina v1.5 Small RNA-Seq
Prep Kit (3′ adapter: TCGTATGCCGTCTTCTGCTTG,
5′ adapter: GTTCAGAGTTCTACAGTCCGACGATC).
In the original report, the adapters were trimmed using
BLAT (35) and then the processed sequences were mapped
directly against the human genome (hg19) with the BWA
aligner. The plasma dataset contains nine different sam-
ples, including plasma samples from three CRC patients,
three Ulcerative Colitis (UC) patients and three normal
controls. The small RNA libraries were generated with the
Illumina v1.5 Small RNA-Seq Prep Kit (3′ adapter: ATCT
CGTATGCCGTCTTCTGCTTG, 5′ adapter: GTTCAG
AGTTCTACAGTCCGACGATC).
RESULTS
Synthetic miRNAs
One of the challenges associated with miRNA
profiling/measurement is the inconsistency of results
from different platforms. This makes it difficult to compare
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data generated from different platforms or to use different
platforms for verification of results. This is especially true
for results between NGS and other platforms, since NGS
does not utilize hybridization of oligonucleotides/primers
for its measurement. To better align the sequencing results
with qRT-PCR and microarray results, we used measure-
ment results from different platforms based on the 286
synthetic miRNAs to evaluate mapping parameters.
The comparison results between different measurement
platforms under different synthetic miRNA composition
are shown in Figure 2. The concentration distribution of
miRNA profiles from miRNA array showed good corre-
lation with input miRNA concentration (Figure 2A). For
example, the third sample––Array 10 1 0.1, with 10 ng, 1
ng and 0.1 ng of pooled miRNAs from plate 1, 2 and 3
respectively, has Log2-transformed hybridization intensi-
ties around 9.5, 6.5 and 3.5 on average for plate 1, 2 and
3. The results from qRT-PCR (qPCR 10 10 10) correlated
with the correspondingmicroarray results (Array 10 10 10,
and Array 10 10 1) (Figure 2B). However, the correlation
between microarray and qRT-PCR results dropped signif-
icantly when lower concentrations of synthetic miRNAs
were involved.
The correlation coefficients betweenmiRNAprofiling re-
sults generated from miRNA array and sRNA-Seq under
different mapping assignment approaches are summarized
in Figure 2C and D. The NGS platform can differentiate
different compositions of synthetic miRNA, and the NGS
mapping results showed good correlation with miRNA ar-
ray (Figure 2E) and qRT-PCR (Figure 2F) data. In general,
NGS results generated using the multiple assignment map-
ping strategy with some mismatch allowance provided bet-
ter correlation with microarray and qRT-PCR results com-
pared to single assignment with no mismatches allowed.
The weighted approach to adjust the contribution for dif-
ferent levels of mismatch on the overall mapping results
further enhanced the correlation between NGS profiling re-
sults with either microarray or qRT-PCR. However, the op-
timal mismatch allowance conditions are different between
microarray and qRT-PCR. For example, multiple assign-
ment with a maximum of twomismatches (using weight ad-
justment factor of one for no mismatch, 0.8 for one mis-
match and 0.6 for two mismatches) showed higher correla-
tion with microarray results, while multiple assignment us-
ing a maximum of one mismatch (using a parameter of one
for no mismatch and 0.8 for one mismatch) showed higher
correlation with qRT-PCR. This is consistent with the idea
that the qRT-PCR basedmeasurement is more specific than
themicroarray-basedmeasurement. However, this may also
depend on differences in PCR primer or microarray probe
design between different vendors. Users can adjust the pa-
rameters to fit their experimental platform and condition.
Nevertheless, sRNAnalyzer provides options to better align
the sequencing results with other platforms, which will be
useful for users to verify sRNA-Seq results with qRT-PCR
or other platforms.
Analyzing small RNA in human samples with sRNAnalyzer
The miRNA mapping can be affected by some common
features associated withmiRNA, including length variation
(isomiR), sequence polymorphism, RNA editing and high
sequence similarity among family members. To solve these
issues, sRNAnalyzer uses a combination of approaches, in-
cluding mapping to miRNA precursors instead of mature
miRNA and different levels of error tolerance in combi-
nation with the LPM. To test the performance of sRN-
Analyzer on complex biological samples, we downloaded
the raw sequencing data of a CRC study from NCBI/SRA
database (SRP022054). The original study used qRT-PCR
to verify several differentially expressed miRNAs identified
by NGS (34).
We used the sRNAnalyzer, with multiple assignment
and maximum of one mismatch, to test whether we could
identify those validated differentially-expressed miRNAs in
CRC. After running the dataset through sRNAnalyzer, we
performed a differential analysis based on the mapping re-
sults. To compare data between different samples across dif-
ferent experiments, the mapped read counts were normal-
ized with Log2-transformed reads per million (RPM) reads
mapped to the reference database at each step. This nor-
malization method is most similar to percentage. The top-
ranked differentialmiRNAs identified by sRNAnalyzer (tu-
mor versus normal) are shown in Table 1 and include all
qRT-PCR verified miRNAs. This suggests that the results
from sRNAnalyzer agree with the original study (34). The
fold changes from the qRT-PCR verification study matched
with results from sRNAnalyzer better than the results from
the original report. For example, miR-1 is the miRNA
showing the most concentration difference in both qRT-
PCR and sRNAnalyzer based analyses.
When one mismatch in miRNA mapping was allowed
(user adjustable), the sRNAnalyzer provided a summary file
containing both match and mismatch profiles (read counts)
for every nucleotide across the miRNA precursor sequence.
An example of summarized read count distributions for
both match and mismatch events for hsa-mir-1–1 is shown
in Figure 3. The mismatch rate at nucleotide position 67
(first nucleotide of the precursor sequence is 0) is lower
in normal tissue samples, compared to metastatic tissues.
Whether this relates to disease status remains to be deter-
mined. This function in sRNAnalyzer allows the user to
identify miRNA associated RNA editing events as well as
sequence polymorphisms.
To show a global view of small RNAs in these tissue sam-
ples, we further performed differential analysis on piRNA,
snoRNA and lncRNA profiles generated from sRNAna-
lyzer with single assignment and no mismatch. From Sup-
plementary Tables S2–4, we can see that there are several in-
teresting small RNAs differentially expressed in tumor tis-
sues and significantly upregulated in metastases tissues.
Exogenous RNA mapping with sRNAnalyzer
Exogenous species-derived RNAs, especially from bacteria
and fungi, have been observed in human and murine sam-
ples (11,13–14,26). Even though the source, abundance and
function of exogenous RNA remains controversial (36), the
ability to accurately quantify and map the origin of exoge-
nous sequences is critical to assess the diversity and possi-
ble function of these RNAs. We incorporated an exogenous
RNA mapping process in sRNAnalyzer.
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Figure 2. Comparison of miRNA profiles from sRNA-Seq, miRNA array and qRT-PCR platforms for synthetic miRNA samples. (A) Distribution of
miRNA profiles frommiRNA array on three plates; (B) Correlation between miRNA profiles frommiRNA array and qRT-PCR; (C) Correlation between
miRNA profiles from miRNA array and sRNA-Seq using single assignment approach; (D) Correlation between miRNA profiles from miRNA array
and sRNA-Seq using multiple assignment approach; (E) Approximation from sRNA-Seq to miRNA array; and (F) Approximation from sRNA-Seq to
qRT-PCR.
The conservation of rRNA and tRNA sequences among
different species often causes mapping issues since a single
read may assign to several hundred species. To obtain more
reliable information on the origin of exogenous RNA, sRN-
Analyzer includes optional rRNA and tRNAfiltering steps.
To test the effect of rRNA and tRNA filtering steps on
the exogenous RNA mapping accuracy, we used the small
RNAseq data from a previous bacterial out membrane vesi-
cle (OMV) study (25). In this study, E. coli K-12 (MG
1655) was cultured in standard LB growth medium and
samples include RNA extracted from bacteria (RNAintra),
bacterial OMV particles (RNAexOMV), OMV-depleted me-
dia (RNAexOMV-free), cultured LB after removing bacteria
(RNALB-cultured) and fresh LB (RNALB).
We first input raw read sequences into the data prepro-
cessing module of our pipeline, including the stop oligo re-
moving step, since these samples were made by Illumina
TruSeq small RNA library kit. For the RNAexOMV sample,
we can see that around 20% reads mapped to the stop oligo
(stp) sequences have been removed (Supplementary Figure
S4), which not only improved the overall mapping rate but
also increased the mapping efficiency.
We then ran the trimmed/clean reads through the re-
maining pipeline, which allowed us to test (i) whether
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Table 1. Differential analysis of miRNA profiles for human tissue samples from a CRC study (GEO accession number: GSE46622 or SRA accession
number: SRP022054)
miRNA T/N FC T/N pVal M/N FC M/N pVal M/T FC M/T pVal
hsa-miR-1–3p −8.22250 0.00221 −12.19746 0.00019 −0.39062 0.25391
hsa-miR-133a-3p −4.76817 0.00251 −8.74696 0.00009 −0.59894 0.10591
hsa-miR-194–1-3P −4.30349 0.02117 −6.83087 0.00324 −0.29064 0.29476
hsa-miR-375 −4.15678 0.01461 −1.40532 0.10508 0.72822 0.22547
hsa-miR-143–5p −4.05022 0.00980 −3.44819 0.00970 0.02421 0.41680
hsa-miR-133b −3.42637 0.00068 −3.98052 0.00014 −0.02076 0.35883
hsa-miR-129–2-3p −3.41944 0.02247 −3.91576 0.00998 −0.01681 0.41124
hsa-miR-129–1-3p −3.39301 0.01807 −3.05203 0.01421 0.00903 0.42976
hsa-miR-1224–5p −3.01311 0.00238 −0.49318 0.23264 1.06825 0.14720
hsa-miR-147b −2.74872 0.02911 −4.74095 0.00365 −0.26982 0.29074
hsa-miR-124–3p −2.70090 0.00639 −1.08949 0.14865 0.35959 0.26224
hsa-miR-490–3p −2.68564 0.02562 −3.50480 0.01366 −0.05444 0.24816
hsa-miR-215–3p −2.64760 0.07514 −5.24797 0.01009 −0.44050 0.29178
hsa-miR-133a-5p −2.31880 0.00400 −3.63812 0.00081 −0.14794 0.13683
hsa-miR-145–3p −2.26530 0.02788 −4.19600 0.00459 −0.29520 0.21543
hsa-miR-96–5p 2.55000 0.01849 4.31795 0.00278 0.23145 0.25813
hsa-miR-182–5p 3.42372 0.03417 7.79898 0.00119 0.88800 0.17776
hsa-miR-183–5p 3.99934 0.01719 7.40056 0.00479 0.51921 0.25077
hsa-miR-135a-5p 4.57508 0.00792 7.91757 0.00206 0.45545 0.20791
hsa-miR-122–5p 5.42554 0.08238 34.37772 0.00572 12.48896 0.06981
hsa-miR-31–3p 6.04394 0.00683 2.12517 0.01529 −1.00130 0.15600
hsa-miR-135b-5p 6.65842 0.00524 10.20095 0.00138 0.37638 0.24436
hsa-miR-31–5p 17.06142 0.00031 10.03755 0.00234 −0.92609 0.17938
Note: N––Normal, T––Tumor, M––Metastasis, FC––Fold Change and pVal––P-Value. Nine miRNAs validated by qRT-PCR in the original study (34)
are highlighted (bold).
Figure 3. Example of summarized read count distributions for every nucleotide for bothmatch andmismatch events across the miRNA precursor sequence
(has-mir-1–1).
the parameters used for endogenous reference sequence
database (mainly for human in this scenario) mapping pro-
cess in sRNAnalyzer would filter out too many informa-
tive bacterial sequences and (ii) whether sRNAnalyzer can
correctly identify the bacterial species. We tested various
options for exogenous mapping including with/without
rRNA/tRNA filtering, and with/without LPM.
Under the settings single assignment with LPM, most of
the RNAintra reads mapped to bacteria (Figure 4A), which
suggests rigorous human reference sequence mapping steps
(allowing two mismatches) do not remove a significant
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Figure 4. Overall mapping ratios and taxonomy summarization for Escherichia coli bacterial culture samples. (A) Overall domain mapping ratios; (B)
Taxonomy summary at Genus level using ribosomal RNA (rRNA) filtering and applying a local probabilistic model (LPM); (C) Taxonomy summary at
Genus level using rRNA filtering but without LPM; and (D) Taxonomy summary at Genus level neither using rRNA filtering nor applying LPM.
fraction of the sequence reads (over 95% of sequence
reads) prior to bacterial sequence database mapping. Un-
like the RNAintra samples, many reads from the RNAexOMV,
RNAexOMV-free, RNALB-cultured andRNALB samplesmapped
to fungi and mammals. This is not surprising since these
four samples were extracted from LBmedium and the stan-
dard LB medium does contain yeast extract and tryptone
(from mammalian milk).
To compare these samples under different analytical ap-
proaches, we used log2 transformedRPMmapped reads. At
the genus level, Escherichia has the most mapped sequence
reads from RNAintra, RNAexOMV and RNAexOMV-free (Fig-
ure 4B). In results for RNAintra, the second top-ranked
genus was Shigella, which is evolutionarily close to Es-
cherichia, followed by Salmonella, which shares 18% of
its genome with E. coli substrain MG1655. It should be
noted that the RNAexOMV and RNAexOMV-free samples were
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more similar to the RNAintra sample at genus (Figure 4B),
species (Supplementary Figure S5) and strain levels (Sup-
plementary Figure S6), even though they are more similar
to RNALB-cultured and RNALB samples at the domain level
(Figure 4A). These results indicated that using default set-
ting, sRNAnalyzer (rRNA/tRNA filtering with LPM) can
successfully identify specific bacterial species from samples.
Escherichia is still the top ranking genus for RNAintra
and RNAexOMV-free samples (Figure 4C), but not for the
RNAexOMV, when LPM was not used. This suggests that
exogenous reference sequence mapping without LPM has
less specificity even if rRNA and tRNA filtering step is ap-
plied. Without rRNA and tRNA filtering, Serratia was in-
correctly identified as the top ranking genus for RNAintra
(Figure 4D). This suggests that the rRNA/tRNA filter step
can improve the accuracy of exogenous sequence mapping.
Analyzing exogenous RNA in human samples with sRNAna-
lyzer
To test the ability of sRNAnalyzer to identify exogenous
RNAs in samples, we used a dataset of plasma samples
from CRC patients that we published earlier (11). The
data contains nine human plasma samples––three from
CRC patients, three from Ulcerative Colitis (UC) patients
and three from healthy individuals (Norm). We used log2-
transformed and RPM normalized data for comparison.
Despite different clinical conditions, the overall profile of
mapped sequence reads at domain level is similar among the
samples (Figure 5A) which is consistent with prior findings.
However, at the genus level, some CRC samples showed
higher concentrations of Pseudomonas (crc1 and crc2) and
Ralstonia (crc2 and crc3) derived sequences compared to
UC and Norm samples (Figure 5B and C).
We further identified RNA derived from two bacterial
species––Pseudomonas fluorescens andRalstonia pickettii in
the three CRC samples that were more abundant than other
samples. When compared to human CRC tissue samples
(34) reanalyzed with sRNAnalyzer, the abundance of RNA
derived from Pseudomonas and Ralstonia were both signif-
icantly higher (>3-fold difference with P-value < 0.05) in
metastatic tissue samples (Figure 6B and C). We did not see
this correlation between tissue and plasma datasets with-
out rRNA/tRNA filtering. This also suggests the potential
of identifying disease-associated exogenous species-derived
RNA in circulation using rRNA and tRNA filtering with
LPM in sRNAnalyzer.
DISCUSSION AND CONCLUSIONS
There are many experimental and data analysis challenges
in the field of small RNA profiling, especially when dealing
with body fluid samples. To improve the reliability of NGS-
based small RNA profiling, sRNAnalyzer adopts a com-
prehensive adapter trimming strategy and sequence qual-
ity assessment in the data preprocessing module. For se-
quence mapping, we developed a flexible database search-
ing approach to fit specific goals for different studies. We
used several public domain datasets to evaluate the perfor-
mance and determine the proper setting of various param-
eters in sRNAnalyzer. In the result summarization module,
sRNAnalyzer provides several reporting formats for users
to view and inspect the mapping results. Compared to other
tools, the sRNAnalyzer hasmany enhanced features includ-
ing (i) modular pipeline design, (ii) rigorous data prepro-
cessing steps, (iii) endogenous and exogenous RNA map-
ping capability, (iv) use of precursor miRNA sequences
annotated with mature sequence information for miRNA
mapping, (v) use of LPM (local probability mapping) strat-
egy to increasemapping specificity, (vi) extensive rRNAand
tRNA filtering steps to enhance the accuracy of exogenous
RNAmapping and (vii) various levels of result summariza-
tion. These features increase the flexibility for users to in-
spect the results and gain a global view of the small RNA
in the sample.
For miRNA profiling, sRNAnalyzer adopted both the
single and multiple assignment approaches as introduced
in sRNAbench (19) to report the miRNA mapping results.
Both approaches support different levels of error tolerance,
from perfect match to two mismatches allowed. The sin-
gle assignment approach based on LPM provides a more
reliable picture of the RNA profile in a sample, while re-
sults from the multiple assignment approach provide bet-
ter agreement with results from other miRNA measure-
ment platforms such as microarray and qRT-PCR, espe-
cially when applying weighted correction factors for differ-
ent levels of mismatch allowance. The final estimation of
the expression values were calculated with all mapped reads
and summarized as miRNA profiling results. This weight
approach actually considered sequence mismatches caused
by all possible reasons including SNPs, RNA editing issues,
as well as sequence errors.
Since a significant fraction of circulating RNAs are the
degraded products of large transcripts, sRNAnalyzer in-
cludes a number of endogenous sequence databases includ-
ing various noncoding RNAs, protein coding transcripts
and genomic DNA to gain a comprehensive profile of RNA
in circulation. For these endogenous sequences, sRNAna-
lyzer uses ‘map and remove’ structure (i.e. only unmapped
reads will be fed into next steps) with progressive align-
ment strategy to sequentially map reads against various
databases. The mapping order of databases and the error
tolerance on each mapping step depend on the research fo-
cus. This strategy can enrich the focused small RNA family,
while may also bring a certain level of bias due to multi-
ple alignments. To avoid this bias, sRNAnalyzer provides a
very convenient way to change the mapping order and mis-
match allowance by simply changing a text-based configu-
ration file instead of reprogramming.
The extensive endogenous sequence mapping step is crit-
ical for exogenous sequence mapping since it removes all
possible endogenous sequence reads. This may also raise
the concern regarding the possibility of removing too many
reads derived from exogenous species. To address this con-
cern, we tested our pipeline using a dataset derived from
RNA samples extracted from cultured bacteria.Most of the
bacteria-derived reads still passed the rigorous endogenous
‘filtering step’ and correctly mapped to bacteria species
(Figure 4A). This suggests that the rigorous human refer-
ence sequence mapping steps (allowing a maximum of two
mismatches) do not remove significant fraction of the bac-
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Figure 5. Overall domain mapping ratios and taxonomy summarization for human plasma samples from an exogenous RNA spectra study. (A) Overall
domain mapping ratios; and (B) Taxonomy summary at Genus level; and (C) Taxonomy summary at Species level for human plasma samples from an
exogenous RNA spectra study (SRA Session: ERP002414).
teria sequence reads (over 95% of sequence reads still re-
mained).
Due to high sequence conservation of rRNA and tRNA
sequences across species, sRNAnalyzer offers users an op-
tion to remove these reads prior to exogenous sequence
mapping.We showed that rRNAand tRNAfiltering is criti-
cal to identify the correct bacterium species in the case study
of bacterial culture samples (Figure 4). To avoid informa-
tion loss, sRNAnalyzer can summarize reads mapped to ex-
ogenous RNAs at different taxonomy levels with or without
considering those filtered rRNAs/tRNAs, although the de-
fault setting is the latter one. In addition, the use of LPM
can further enhance the specificity of exogenous RNAmap-
ping. Our pipeline can also be used for samples from differ-
ent species bymaking specific databases for different species
and changing the order of mapping steps in the configura-
tion files. Currently we have configuration files for human,
mouse, rat, horse, macaque and plant for different research
focuses.
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Figure 6. Overall mapping ratios and taxonomy summarization for human tissue samples from a CRC study. (A) Overall domain mapping ratios; (B)
Taxonomy summary on Pseudomonas; and (C) Distribution of taxonomy summary on Pseudomonas for human tissue samples from a CRC study (SRA
Session: SRP022054).
In summary, sRNAnalyzer is a full function, customiz-
able small RNA analysis pipeline for NGS data. It can ef-
fectivelymap both endogenous and exogenousRNA. It also
offers different levels of detail in the mapping results––from
individual sequence reads, transcripts, species to domain.
This allows users to gain a better picture of the complexity
of small RNA in samples.
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